DrugPatentWatch Database Preview
Drugs in Development Information for Dorzagliatin
Drug Development Status for Dorzagliatin: Sponsors, patents, clinical trial progress
Dorzagliatin is an investigational drug.
There have been 4 clinical trials for Dorzagliatin.
The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2019.
The most common disease condition in clinical trials is [disabled in preview]. The leading clinical trial sponsors are Hua Medicine Limited and [disabled in preview].
There are two US patents protecting this investigational drug and forty-eight international patents.
Summary for Dorzagliatin
| US Patents | 2 |
| International Patents | 48 |
| US Patent Applications | 2 |
| WIPO Patent Applications | 2 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2019-01-01) |
| Vendors | 5 |
Recent Clinical Trials for Dorzagliatin
| Title | Sponsor | Phase |
|---|---|---|
| Drug Interaction Study Between Dorzagliatin and Empagliflozin | Hua Medicine Limited | Phase 1 |
| Drug Interaction Study Between Dorzagliatin and Sitagliptin | Hua Medicine Limited | Phase 1 |
| DDI Study Between Dorzagliatin and Rifampicin | Hua Medicine Limited | Phase 1 |
Clinical Trial Summary for Dorzagliatin
Top disease conditions for Dorzagliatin
Top clinical trial sponsors for Dorzagliatin
US Patents for Dorzagliatin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Dorzagliatin | Start Trial | Pyrrolidinone glucokinase activators | Hoffmann-La Roche Inc. (Nutley, NJ) | Start Trial |
| Dorzagliatin | Start Trial | Process for the preparation of 1-([1,3]dioxolan-4-ylmethyl)-1H-pyrazol-3-ylamine | HUA MEDICINE (Grand Gayman, KY) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Dorzagliatin
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Dorzagliatin | Argentina | 071474 | 2028-04-16 | Start Trial |
| Dorzagliatin | Austria | 557017 | 2028-04-16 | Start Trial |
| Dorzagliatin | Australia | 2009237794 | 2028-04-16 | Start Trial |
| Dorzagliatin | Canada | 2720524 | 2028-04-16 | Start Trial |
| Dorzagliatin | China | 102007118 | 2028-04-16 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
